1. Aquaglyceroporins: Drug Targets for Metabolic Diseases?
   Giuseppe Calamita et al, 2018, Frontiers in Physiology CrossRef
2. Ovarian Hormonal Change-Related Energy Metabolism and Obesity in Menopausal Women
   Jing Zhu et al, 2020, Hormone Therapy and Replacement in Cancer and Aging-related Diseases CrossRef
3. In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease
   Xiang-Yu Zhu et al, 2020, Toxicology Letters CrossRef
4. Aquaglyceroporin Modulators as Emergent Pharmacological Molecules for Human Diseases
   Catarina Pimpão et al, 2022, Frontiers in Molecular Biosciences CrossRef
5. Implications of Aquaglyceroporin 7 in Energy Metabolism
   Francesco Iena et al, 2018, International Journal of Molecular Sciences CrossRef
6. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause
   Ralitsa Robeva et al, 2021, Maturitas CrossRef
7. Tissue-specific effects of estrogen on glycerol channel aquaporin 7 expression in an ovariectomized mouse model of menopause
   B. Jin et al, 2017, Climacteric CrossRef
8. Activation of Estrogen Response Element–Independent ERα Signaling Protects Female Mice From Diet-Induced Obesity
   Ali Yasrebi et al, 2017, Endocrinology CrossRef
9. A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease
   Arezoo Gowhari Shabgah et al, 2021, Nutrition & Metabolism CrossRef
10. NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment
    Johanna K DiStefano, 2020, Endocrinology CrossRef
11. The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis
    Taylor Phelps et al, 2019, Biology of Sex Differences CrossRef
12. Involvement of aquaglyceroporins in energy metabolism in health and disease
    Giuseppe Calamita et al, 2021, Biochimie CrossRef
13. Synthesis, Regulatory Factors, and Signaling Pathways of Estrogen in the Ovary
    Chuyu Xiao et al, 2023, Reproductive Sciences CrossRef
14. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
    Vasiliki Venetsanaki et al, 2019, Current Vascular Pharmacology CrossRef
15. Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells
    Xiaohua Fu et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
16. Single neonatal estrogen implant sterilizes female animals by decreasing hypothalamic KISS1 expression
    Chan Jin Park et al, 2023, Scientific Reports CrossRef
17. Standardized rice bran extract improves hepatic steatosis in HepG2 cells and ovariectomized rats
    Dong Wook Lim et al, 2020, Nutrition Research and Practice CrossRef
18. Transcriptomic analysis of the liver in aged laying hens with different intensity of brown eggshell color
    Gi ppeum Han et al, 2021, Animal Bioscience CrossRef
19. Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD
    Kelly McCall et al, 2023, Journal of Inflammation Research CrossRef